Atlas Trials

Study for Verification of Efficacy and Safety for Perampanel Monotherapy in Untreated Participants With Partial Onset Seizures (Including Secondarily Generalized Seizures (FREEDOM Study)

Clinical trial NCT03201900 · COMPLETED

Trial details

NCT number
NCT03201900
Sponsor
Eisai Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Partial Onset Seizures
Start date
2017-06-28
Primary completion
2019-02-28
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.